Bonnie L. Bassler, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,021 shares at $779.00 ($795K) on 2023-02-03, disclosed to the SEC on 2023-02-07.
Open-market sale of $795k REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| REGN | SELL | 2024-08-19 | $885K | — | Filing → |
| REGN | SELL | 2024-08-05 | $843K | — | Filing → |
| REGN | SELL | 2024-06-25 | $803K | — | Filing → |